to increased urgency and increased frequency, especially at night. No single causative factor has been identified for BPH or prostate cancer, though numerous factors have been proposed, including diet, endocrine signaling from androgens or estrogens, genetic susceptibilities, and exposure to environmental carcinogens. However, one pathological feature is dominant in proliferative prostatic diseases:
continual and recalcitrant inflammation. 3 Inflammation of the human prostate is a critical area of urological research due to its common concurrence with prostate cancer and BPH. [4] [5] [6] Prostatic inflammation is diagnosed histologically from the presence of inflammatory cells infiltrating the prostatic stroma, epithelium, and lumen of prostate glands. 7 In the transitional zone of the human prostate, the cellular nature inflammation is primarily lymphocytic with secondary accompanying macrophages juxtaposed to loci of reactive hyperplasia. 8 Additionally, inflammation in the prostate associates with dysplastic changes including focal disruption of the epithelium, polymorphisms of epithelial cell nuclei, and increased epithelial proliferation, and proliferative atrophy. 2, 3 Human prostatectomy specimens exhibit proliferating epithelial cells and activated inflammatory cells juxtaposed to neoplasia and hyperplastic glands. Numerous prostate disease susceptibility genes function in the inflammatory response. 4, 5 Sustained cell proliferation in an environment rich in inflammatory cells, growth factors, and reactive stroma, potentiate prostatic epithelial growth. 9 Interleukins 1 and 6, tumor necrosis factor, and prostanoids all promote tumor cell growth in culture, and all are increased in both BPH and prostate cancer specimens relative to controls. [10] [11] [12] In addition, prostatic inflammation is associated with more severe symptoms and an increased risk for clinical progression of BPH, 13 as there is a clear correlation of inflammation with BPH symptom severity. 14 The origins of inflammation in the prostate are likely multifactorial and may include bacterial colonization by culturable or non-culturable organisms, 15, 16 viruses, environmental, and dietary components, systemic androgen and estrogens, associations with metabolic syndrome, and urinary reflux of any of these noxious stimuli into the prostatic ducts. 17 However, the role each may play in the etiology of human prostatic inflammation still remains unclear.
Toxoplasmosis and various pathologies correlated with chronic toxoplasmosis, such as systemic lupus erythematosus 18 and inflammatory bowel disease, 19 have an inflammatory component. [18] [19] [20] [21] [22] [23] [24] [25] Toxoplasmosis is caused by the common parasite, Toxoplasma gondii, an obligate intracellular protozoan capable of infecting any nucleated mammalian or avian cell. 26 Serology testing has confirmed that almost 1/3 of the western population has been exposed to T. gondii, with certain populations showing an infection rate as high as 80%. 27, 28 Humans can become infected through multiple routes, including the ingestion of oocysts deposited into the environment by felines (the definitive host) in their feces, ingestion of tissue cysts in the raw or undercooked meat of infected animals, and congenital transmission across the placenta. Upon initial infection, immune competent individuals may experience mild flu-like symptoms as the immune response prompts the rapidly replicating form of the parasite (tachyzoite) to convert into a latent tissue cyst form (bradyzoite).
Bradyzoite tissue cysts, which can be found at high frequency in the brain and muscular tissue, allow T. gondii to persist as a lifelong chronic infection in the host. 29, 30 Impervious to current drug treatments, the tissue cysts are not eradicated from the host and can reactivate into the proliferative form if immunity becomes compromised. Since the latent cyst stage of T. gondii had not been associated with symptomology or pathogenesis in the immunocompetent, little attention has been given to its presence in specific infected organs.
In this report, we show for the first time that T. gondii promotes prostatic inflammation and the subsequent reactive hyperplasia in mice. Furthermore, we present a comprehensive characterization of a murine model of chronic prostatic inflammation, one which persists and progresses in severity without genetic manipulation.
| MATERIALS AND METHODS

| Parasites strains and culture
T. gondii parasites of strain PruΔhxprt + ldh2GFP (aka PruΔC32) 31 were grown on human foreskin fibroblasts (HFF) obtained from ATCC. HFFs were maintained in Dulbecco's medium supplemented with 10% heat-inactivated fetal bovine serum (FBS), 2 mM L-glutamine, 100 U/mL penicillin, and 100 µg/mL streptomycin in a humidified incubator at 37°C with 5% CO 2 .
| Animal infections
All mice used in this study were housed at the Indiana University 
| Inflammatory scoring
Tissue sections were stained with hematoxylin and eosin and viewed on a Leica DM 2500 microscope. Three random 10X images/mouse were taken using a Leica 2500 microscope and DCF425C Camera and analyzed with LASX software. Inflammatory response of the DLP, AP, and VP were scored in a blinded manner and graded based on severity and focality of inflammatory infiltrate and epithelial hyperplasia as previously described. 34 
| Protein extraction
Flash frozen prostate tissues were placed into 1.5 mL screw cap tubes with 500 μL ice-cold lysis buffer (0.12 g Tris base, 0.9g NaCl in 100 mL of ddH 2 0, pH to 8.0, Halt Protease/Phosphatase Inhibitor Cocktail:
1:100) (CAT#: 78446, Thermo) and minced into ∼1 mm pieces.
Prostates were homogenized using a Power Gen 125 on ice for no longer than 5 min. A total of 1% v/v of Triton-X was added to each vial and slurries were incubated on ice for one hour with periodic vortexing. Vials were then centrifuged at 14 500 rpm for 10 min. The supernatant was removed and stored in −80°C until use. Signal West Femto and Pico Chemiluminescent Substrate (CAT# 34095, 34078, Thermo) developing reagents at 1:10 and allowed to incubate for 5 min. Developed GFP blots were exposed to films for 5 min and Actin blots were exposed for 1 min before processing. T. gondii localization and chronic encystation in the mouse prostate was visualized by immunofluorescence in all infected mice prostates at 14, 28, and 60 DPI. Dorsal lateral prostate (DLP) sections from infected mice for the time indicated were co-stained for T. gondii-expressed GFP (green) and the T. gondii specific cyst wall marker Dolichols biflorus agglutinin (DBA) conjugated to rhodamine (red). 36 Arrow heads denote T. gondii cysts; scale bars mark 25 μm. Serial section of the GFP/DBA stained slides, stained with hematoxylin and eosin (H&E). Arrow heads denote T. gondii cysts; scale bars mark 25 μm. (C) To confirm specificity of T. gondii labeling, 60 days prostates were co-stained with bradyzoite antigen (Bag1), the parasite specific heat shock protein, Hsp30 (green), and DBA (red) and are shown in an 80X image. 33 Scale bars represent 25 μm
| Western blotting
| Flow cytometry
Mouse prostates were processed into single-cell suspensions and intracellular and extracellular markers of interest were labeled as previously described. 35 Before applying primary antibodies to the cells, non-specific Fc Receptor binding was blocked using 0.5 μg/ Analysis was performed using FloJo Software.
Single-color compensation controls for each experiment were prepared using UltraComp eBeads (CAT#: 00-4222, eBioscience).
Autofluorescence was controlled for using unstained cells and fluorochrome conjugated isotype antibodies.
T-cell and dendritic cell analysis was performed using antibodies at the following concentrations: 0. gondii infected mice at 14, 28, and 60 DPI, (n = 6-10, each group) using the established scoring system published by Boehm et al. 34 Data are presented as the mean inflammatory infiltrate score ± SEM and compared to uninfected control mice by two-tailed student's Prostates were assessed for the presence of various parasite-specific markers at 14 days post infection (DPI), at which time the infection is mostly in the acute tachyzoite stage, and at 28 and 60 DPI to monitor chronic infection. 29, 30 Using Western blot GFP was detected in infected mice at all three time points of harvest, but was absent in the uninfected controls (Fig. 1A) . We next analyzed prostate tissues by immunofluorescence assay (IFA) andcostained prostates with rhodamine conjugated-Dolichos biflorus agglutinin (DBA), a lectin that binds terminal α-N-acetylgalactosamine residues on the parasite's tissue cyst wall and GFP. 36 Structures exhibiting the characteristic staining pattern for tissue cysts were found at each time point (Fig. 1B) . To further confirm that the GFP/DBA-positive structures in the prostates of infected mice were parasite tissue cysts, we co-stained prostate samples with DBA and bradyzoite antigen 1 (BAG1), a bradyzoitespecific heat shock protein (Fig. 1C) . 33 Structures staining with both reagents were observed (Fig. 1C) , indicating the presence of bradyzoite cysts in the infected prostate samples. We did not see DBA staining in uninfected mice, or in prostates of Escherichia coli 1677 instilled C57/B6 mice, indicating that the presence of DBA staining is specific to T. gondii and not a general effect of infection.
Collectively, these results indicate that T. gondii chronically encysts in the mouse prostate and can persist in this organ for at least 60 days post infection.
| T. gondii infection induces chronic prostatic inflammation
We next sought to determine if T. gondii infection caused inflammation in the mouse prostate. We assessed the presence of inflammatory infiltrates in longitudinal sections from infected or control prostates at 14, 28, and 60 DPI using hematoxylin and eosin (H&E) stain. Infiltrating leukocytes were detected in all samples from infected animals and appeared to be significantly increased in numbers compared to uninfected animals ( Fig. 2A) . To quantitate this effect, we used an established scoring system 34 that measures inflammatory infiltrate based on the intensity, severity and focality. T. gondii induced a significant inflammatory reaction in all prostatic lobes at 14 and 28 DPI relative to uninfected age-matched vehicle control mice (Fig. 2B) . All lobes exhibited similar inflammatory distribution and intensity throughout the time course of infection. At 14 DPI each lobe exhibited moderate inflammatory infiltrate, however; the dorsal lateral prostate (DLP) lobes exhibited the most pronounced timedependent increase in inflammatory score, progressing from a score of 5.04 at 14 DPI to a score of 7.17 by 60 DPI (Fig. 2B) . These data indicate that T. gondii infection in the prostate induces chronic inflammation in all lobes of the prostate, which increases in severity during persistent infection.
| T. gondii induces a predominantly T-cell immune response in the prostate
As the DLP was found to have the most reproducible and consistent presence of leukocytes by H&E staining, we chose this lobe for further , and Cd11c+/CD8α+ dendritic cells (white portion) in T. gondiiinfected and age-matched control mice at 28 DPI. Data are presented as mean ratio to total live cells ± SEM; infected and control groups were compared by two-tailed student's t-test. *P < 0.05 (n = 6) characterization of the inflammatory response to T. gondii infection of the prostate. We probed for lymphocytic and monocytic markers CD20, F4-80, and CD3 by immunofluorescence to identify B lymphocytes, monocytes, and lymphocytes, respectively (Fig. 3A) .
To quantify individual immune cell types, we analyzed whole prostates by flow cytometry. As predicted by our immunofluorescence assays, there was a significant increase the percent of immune cells as a proportion of total live cells (identified by the pan-leukocyte marker, CD45) in infected animals relative to vehicle treated control (16.43% infected vs 8% control; P = 0.0026) (Fig. 3B ). This increase is primarily attributed to a significant increase of T-lymphocytes as identified by their expression of CD3 (8.2% infected vs 2% control; P = 0.0106) and dendritic cells identified as CD11c and CD8α positive (0.48% con vs 1.28% infected vs 0.48% control; P = 0.0006) (Fig. 3B ).
In total, the CD45 + cell population of infected prostates 
| T. gondii induces reactive epithelial hyperplasia
As inflammatory infiltrate contributes to the release of numerous pro-inflammatory cytokines and chemokines that promote the establishment of a reactive microenvironment that results in reactive epithelial hyperplasia, we sought to determine if T. gondii infection of the prostate results in reactive hyperplasia. Infected and uninfected age-matched control prostates were evaluated for epithelial hyperplasia, which is defined as the multi-layering of epithelial cell layers and dysplasia of expanded basal or cuboidal cells juxtaposed to inflammatory infiltrate (Fig. 4A) . 37 Significant levels of hyperplasia were detected in all sections from infected animals, an observation that was quantified using the scoring system described by Boehm et al. 34 (Fig. 4B) . These findings suggest that T. gondii establishes a chronic inflammatory microenvironment, leading to reactive epithelial hyperplasia in all lobes of the mouse prostate.
As the DLP exhibited the most reproducible, progressive, and pronounced hyperplastic response within the prostate, this lobe was selected for further characterization. To quantify epithelial Hyperplasia scores from DLP, VP, and AP of age-matched-control and T. gondii-infected mice at 14, 28, and 60 DPI (n = 6-10, each group) using the scoring system established by Boehm et al. 34 Data are presented as the mean hyperplasia score ± SEM. Infected mice are compared to uninfected control mice by two-tailed student's t-test. *P < 0.05
proliferation, control and infected mice were injected with bromodeoxyuridine (BrdU) to label replicating cells, and the prostates were harvested 2 h later. We visualized BrdU incorporation into replicating DNA by immunofluorescence and found that T. gondii infection significantly increased the ratio of proliferating epithelial cells at all time points relative to uninfected controls (Fig. 5A,B) . These results parallel the histological epithelial hyperplasia scores, and further demonstrate that T. gondii-induced CK8 ). 38 Numerous foci of both luminal and basal hyperplasia were observed in the hyperplastic regions of infected mice (Fig. 5C ). Proposed transit amplifying cells (TAC), which express both basal and luminal epithelial cytokeratins (CK5 and CK8), 39 were prominent in infected prostates but were rarely observed in uninfected control mice. These data indicate that TAC populations increase in response to infection.
Careful inspection of H&E stained sections revealed a unique histological patterning only observed in infected prostates. At 28 DPI we began to observe the formation of small, round, and connected glandular structures within the epithelial compartment of inflamed prostates (Fig. 6 ). These small micro-glandular formations remained contained within the basement membrane and may maintain their functionality as evidenced by proteinaceous fluid (Fig. 6 ) in their lumens. Additionally, substantial inflammatory infiltrate was commonly juxtaposed to these regions of microglandular hyperplasia. This phenotype was absent in aged-matched uninfected mice, and is observed in 13 out of 16 infected prostates at 28 days and is fully penetrant at 60 DPI (6/6). These observations indicate that chronic T. gondii infection elicits proliferative inflammatory microglandular hyperplasia in the mouse prostate. Future studies will be directed at answering this complex question, as well as determining how long T. gondii infection persists in the prostate. Infections of greater than 1 year could be resolved, or could be associated with more severe prostate disease, and or future work will answer this critical question.
Based on our results, we propose that T. gondii-infected mice can serve as a powerful new model of prostatic inflammation, one ing. 35, 49 Additionally, hormone models yield many off-target and systemic effects making data interpretation difficult. Finally, each of the models produce variable responses. 34, 35, [46] [47] [48] [49] [50] It has become increasingly accepted that inflammation is a causative and driving factor of prostate diseases such as BPH and prostate cancer. 
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